Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Jeffrey Kooper"'
Publikováno v:
Journal of Oncology Pharmacy Practice. :107815522311719
Introduction Ibrutinib is a tyrosine kinase inhibitor approved for multiple B-cell malignancies, including Waldenstrom's macroglobulinemia in 2014. Although the drug portends favorable outcomes, it also bears a profile of side effects. Current litera
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::75088d7ef891ae10b0aff5d09a4bc031
https://doi.org/10.1177/10781552231171925
https://doi.org/10.1177/10781552231171925
Publikováno v:
Annals of Allergy, Asthma & Immunology. 98:490-492
Background Opportunistic infections commonly occur in immunocompromised patients; however, it is unusual for an adult to present with a combined cellular and humoral immunodeficiency. Cryptococcal meningitis is a fatal condition if untreated and is u
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c8ea2aae67c232d12789df4473f0286b
https://doi.org/10.1016/s1081-1206(10)60765-x
https://doi.org/10.1016/s1081-1206(10)60765-x
Supplemental material, sj-docx-1-opp-10.1177_10781552231171925 for Serositis causing pericardial and pleural effusions after eight years of maintenance ibrutinib for Waldenstrom's macroglobulinemia by Grace Johnson, Niharika Baviriseaty, Nicholas Mas
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1362b780bfce21569cb36459c249a8ca
Publikováno v:
Hematology Week; 5/30/2023, p420-420, 1p